Please assess the completion status of the following clinical trial:

Trial Title: Phase 1 Study of DW-0919 & DW-0920 in Healthy Male Volunteers Under Fasting Condition

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Adult males aged 20 to 55 years at screening.~* No significant congenital/chronic disease.~* No symptoms in physical examination.~* Appropriate subjects as determined by past medical history, laboratory tests, serology and urinalysis.~* Be able to understand the objective, method of the study, the characteristics of investigational drug, and comply with the requirement of the study. Subject must provide written informed consent prior to study participation.~Exclusion Criteria:~* History of Hyperreactivity with drug ingredients(acetaminophen, tramadol) or opioids.~* History or presence of liver, kidney, or nervous system disease, respiratory disorders, endocrinological disorders, hemato-oncologic, cardiovascular or psychiatric or cognitive disorders.~* History of gastrointestinal disorders (bleeding, ulceration, hemorrhoids, piles) or disorders of absorption, distribution, metabolism, excretion.

- Gender: MALE
- Minimum Age: 20 Years
- Maximum Age: 55 Years
- Healthy Volunteers: t

Study Arms:
- DW-0919 (Type: ACTIVE_COMPARATOR): None
- DW-0920 (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).